Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06552000 · ClinicalTrials.gov registry record · NA
Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT06552000 is a NA study that has not yet begun recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 18 participants.
The verdict
NCT06552000, a NA study, has not yet begun recruiting, sponsored by University of Texas Southwestern Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to study the clinical and biologic effects of Tumor Treatment Fields (TTFields) in patients undergoing resection of stage I-IIIA Non-Small Cell Lung Cancer (NSCLC). TTField is a non-invasive treatment that uses low-intensity electrical fields to treat cancer. Resection is the medical term for surgically removing part or all of a tissue, structure, or organ.
Interventions
- DEVICE NovoTTF-200T System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2030-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06552000
The ClinicalTrials.gov registry entry for NCT06552000 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NovoTTF-200T System is the first listed.
NCT06552000 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06552000 about?
NCT06552000 is a clinical study titled "Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer". The purpose of this study is to study the clinical and biologic effects of Tumor Treatment Fields (TTFields) in patients undergoing resection of stage I-IIIA Non-Small Cell Lung Cancer (NSCLC). TTField is a non-invasive treatment that uses low-intensity electrical fields to treat cancer. Resection i...
What is the current status of trial NCT06552000?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2026-07-01. Estimated completion is 2030-12-01.
What interventions are being tested in trial NCT06552000?
The interventions under investigation include: NovoTTF-200T System (DEVICE).
Who is sponsoring clinical trial NCT06552000?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.